Quarterly ResultJul 28, 2026, 06:07 AM
SNDL Gains Majority Economic Exposure to Parallel; Q2 Net Loss $(7.8M)
AI Summary
SNDL Inc. reported a net loss of $(7.8) million for Q2 2026, a decline from a net income of $2.9 million in Q2 2025, with net revenue decreasing to $235.8 million. The company announced the completion of the Parallel restructuring, gaining indirect majority economic exposure and expecting to assume direct control of U.S. medical cannabis operations. This positions SNDL to potentially become the first NASDAQ-listed company to consolidate U.S. medical cannabis operations.
Key Highlights
- SNDL completed the restructuring of Parallel, gaining indirect majority economic exposure.
- The company expects to assume direct control of Parallel's U.S. medical cannabis operations.
- Net revenue for Q2 2026 was $235.8 million, down from $244.8 million in Q2 2025.
- Net loss for Q2 2026 was $(7.8) million, compared to net earnings of $2.9 million in Q2 2025.
- Basic and diluted loss per share for Q2 2026 was $(0.03), down from $0.01 in Q2 2025.
- Cash and cash equivalents decreased to $183.2 million as of June 30, 2026, from $252.2 million.
- The second closing of the 1CM acquisition for 27 cannabis retail stores will not proceed.
- SNDL launched the Rise Rewards loyalty program for Ace Liquor and Liquor Depot in March 2026.
Price Impact
More from SNDL